Gamma interferon in experimental leprosy.
We have shown that preactivated MACs are able to cope with newly acquired leprosy bacilli, and a high intracellular burden of live M. leprae induces a refractory response of the host MAC to activation by IFN-gamma. Our studies underscore the fact that MAC function in LL is dependent on localized conditions, influenced by the high intracellular burden of leprosy bacilli and, in part, involving the production of prostanoids. These findings preclude inferences about the function of granuloma MAC s in leprosy based on the responses of MACs from other easily accessible anatomical compartments such as the peritoneal cavity or peripheral blood. We feel that the clearance of bacilli from the LL lesion as a consequence of local immunotherapeutic measures or chemotherapy likely depends on the influx of new competent MAC rather than the activation of resident lepromatous MACs.
Krahenbuhl
J L
JL
Gillis W. Long Hansen's Disease Center, Carville, Louisiana 70721.
Sibley
L D
LD
Chae
G T
GT
D000818:Animals; D007167:Immunotherapy; D007371:Interferon-gamma / Q000276:immunology / Q000627:therapeutic use*; D007918:Leprosy / Q000628:therapy*; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D009166:Mycobacterium leprae / Q000276:immunology
D007371:Interferon-gamma